Finlandiya -
Fince -
Fimea (Suomen lääkevirasto)
dilmin 120 mg depottabletti
ratiopharm gmbh - diltiazem hydrochloride - depottabletti - 120 mg - diltiatseemi
Finlandiya -
Fince -
Fimea (Suomen lääkevirasto)
ismexin 20 mg tabletti
ratiopharm gmbh - isosorbidi 5-mononitras - tabletti - 20 mg - isosorbidimononitraatti
Finlandiya -
Fince -
Fimea (Suomen lääkevirasto)
tamsumin 0.4 mg säädellysti vapauttava kapseli, kova
ratiopharm gmbh - tamsulosin hydrochloride - säädellysti vapauttava kapseli, kova - 0.4 mg - tamsulosiini
Finlandiya -
Fince -
Fimea (Suomen lääkevirasto)
octostim 15 mikrog/ml injektioneste, liuos
ferring lÄÄkkeet oy - desmopressin acetate - injektioneste, liuos - 15 mikrog/ml - desmopressiini
Avrupa Birliği -
Fince -
EMA (European Medicines Agency)
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kana - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
Avrupa Birliği -
Fince -
EMA (European Medicines Agency)
prevexxion rn+hvt+ibd
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.
